Skip to content

Clinical trials

Immunoglobulin Light-chain Amyloidosis trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immunoglobulin Light-chain Amyloidosis Country / region: China Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20181
20191
20203
20211
20221
20232
20246
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting13
Unknown status6
Enrolling by invitation2
Active, not recruiting2
Withdrawn2
Not yet recruiting2
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanjing University School of Medicine4
Peking Union Medical College Hospital4
Peking University People's Hospital4
Alexion Pharmaceuticals, Inc.2
Beijing Boren Hospital2
Jin Lu, MD2
Anhui Provincial Hospital1
Beijing Anzhen Hospital1
Gracell Biotechnologies (Shanghai) Co., Ltd.1
Guangdong Provincial People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immunoglobulin Light-chain Amyloidosis29
Amyloidosis5
Paraproteinemias3
Multiple Myeloma2
Amyloid Neuropathies, Familial1
Leukemia, Plasma Cell1
Neoplasms, Plasma Cell1
Recurrence1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.